CFO
CNMD icon

CVA Family Office’s CONMED CNMD Stock Holding History

CVA Family Office’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7
Closed -$503 – 1299
2024
Q3 		$503 Buy
+7
New +$494 ﹤0.01% 1217

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CVA Family Office's CNMD Position: Q4 2024 in Review

CVA Family Office sold out of CONMED (CNMD) in Q4 2024, closing a stake of 7 shares — an estimated $503 sold.

CVA Family Office first reported a position in CNMD in Q3 2024 and held it in 1 quarter. The position peaked at $503 in Q3 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

  • CVA Family Office reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
  • CVA Family Office sold 7 CONMED shares in Q4 2024, an estimated $503.
  • CVA Family Office first reported a position in CONMED in Q3 2024 and held it in 1 quarter.
  • CVA Family Office's CONMED position peaked at $503 in Q3 2024.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on CVA Family Office's 13F filing for Q4 2024, filed 7 Jan 2025.